Advanced Biomed Inc. (NASDAQ:ADVB – Get Free Report) was the recipient of a significant drop in short interest in April. As of April 30th, there was short interest totaling 13,424 shares, a drop of 72.7% from the April 15th total of 49,188 shares. Currently, 1.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 44,188 shares, the short-interest ratio is currently 0.3 days.
Analysts Set New Price Targets
Separately, Weiss Ratings initiated coverage on shares of Advanced Biomed in a research note on Monday, January 26th. They issued a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.
Check Out Our Latest Research Report on ADVB
Advanced Biomed Stock Performance
Advanced Biomed Company Profile
Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.
Featured Articles
- Five stocks we like better than Advanced Biomed
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Advanced Biomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Biomed and related companies with MarketBeat.com's FREE daily email newsletter.
